Impact of 18F-FDG PET/CT on the therapeutic management in the initial staging of the esophageal cancer;Impacto clínico de la PET/TAC con 18F-FDG en el manejo terapéutico de pacientes con diagnóstico inicial de cáncer de esófago

Revista Espanola de Medicina Nuclear

Volumn 28, Issue 3, 2009, Pages 101-105

  Pifarre Montaner P ^a   Fernandez Leon A ^a   de Juan, R ^a   del Ama Salvador, M E ^a   Galan M ^a   Gamez Cenzano C ^a   Sans, M ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Computed tomography; Esophageal carcinoma; PET CT; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER INFILTRATION; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; ESOPHAGUS CANCER; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CASE MANAGEMENT; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67649212134     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1016/S1578-200X(09)70017-8     Document Type: Article

References (25)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. Unit of Descriptive Epidemiology, International Agency for Research on Cancer, Lyon, France.
2. Akiyama H., Masahiko T., Udagawa H., and Kihyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 220 (1994) 364-373
3. Lerut T., de Leyn P., and Cososemans W. Surgical strategies in esophageal cancer carcinoma with emphasis on radical lymphadenectomy. Ann Surg 216 (1992) 583-590
4. Skinner D.B. En bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg 85 (1983) 59-71
5. Goldberg M., Farma J., and Lampert C. Survival following intensive preoperative combined modality theraphy with paclitaxel, cisplatin, 5-fluorouracil and radioation in respectable esophageal carcinoma. J Thorac Cardiovasc Surg 126 (2003) 1168-1173
6. Räsänen J.V., Sihvo E.I., Knuuti M.J., Minn H.R., Luostarinen M.E., and Laippala P. Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction. Ann Surg Oncol 10 (2003) 954-960
7. Wallace M.B., Nietert P.J., Earle C., Krasna M.J., Hawes R.H., Hoffman B.J., et al. An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound. Ann Thorac Surg 74 (2002) 1026-1032
8. Berrisford R.G., Wong W.L., Day D., Toy E., Napier M., Mitchell K., et al. The decision to operate: role of integrated computed tomography positron emission tomography in staging oesophageal and oesophagogastric junction cancer by the multidisciplinary team. J Cardiothorac Surg 33 (2008) 1112-1116
9. Katsoulis I.E., Wong W.L., Mattheou A.K., Damani N., Chambers J., and Livingstone J.I. Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study. Int J Surg 5 (2007) 399-403
10. Wong W.L., and Chambers R.J. Role of PET/PET CT in the staging and restaging of thoracic oesophageal cancer and gastro-oesophageal cancer: a literature review. Abdom Imaging 33 (2008) 183-190
11. American Joint Committee on Cancer (AJCC). Cancer staging book. 2002.
12. Rice T.W. Clinical staging of esophageal carcinoma. CT, EUS, and PET. Chest Surg Clin N Am 10 (2000) 471-485
13. Cortés-Funes H. Contribution of PET-CT in diagnostic-therapeutic decisions in Medical Oncology. Rev Esp Med Nucl 27 (2008) 79-82
14. Flamen P., Lerut A., Van Cutsem E., De Wever W., Peeters M., Stroobants S., et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 18 (2000) 3202-3210
15. Fukunaga T., Okazumi S., Koide Y., Isono K., and Imazeki K. Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET. J Nucl Med 39 (1998) 1002-1007
16. Kobori O., Kirihara Y., Kosaka N., and Haraa T. Positron emission tomography of esophageal cancer using 11C-choline and F-fluordesoxyglucose: a novel method of preoperative lymph node staging. Cancer 86 (1999) 1683-1748
17. Buenaventura P., and Luketich J.D. Surgical staging of esophageal cancer. Chest Surg Clin N Am 10 (2000) 487-497
18. Lightdale C.J. Esophagueal cancer: practice guidelines. Am J Gastroenterol 94 (1999) 20-29
19. Block M.I., Patterson G.A., Sundaresan R.S., Bailey M.S., Flanagan F.L., Dehdashti F., et al. Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 64 (1997) 770-776
20. Kim K., Park S.J., Kim B.T., Lee K.S., and Shim Y.M. Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography. Ann Thorac Surg 71 (2001) 290-294
21. Chandawarkar R.Y., Kakegawa T., Fujita H., Yamana H., and Hayabuthi N. Comparative analysis of imaging modalities in the preoperative assessment of nodal metastasis in esophageal cancer. J Surg Oncol 61 (1996) 214-217
22. Poon R.T., Law S.Y., Chu K.M., Branicki F.J., and Wong J. Multiple primary cancers in esophageal squamous cell carcinoma: incidence and implications. Ann Thorac Surg 65 (1998) 1529-1534
23. Van Rees B.P., Cleton-Jansen A.M., Cense H.A., Polak M.M., Clement M.J., Drillenburg P., et al. Molecular evidence of field cancerization in a patient with 7 tumors of the aerodigestive tract. Hum Pathol 31 (2000) 269-271
24. Castellsague X., Quintana M.J., Martínez M.C., Nieto A., Sánchez M.J., Juan A., et al. The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis. Int J Cancer 108 (2004) 741-749
25. Weber W.A., Ott K., Becker K., Dittler H.J., Helmberger H., Avril N.E., et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 19 (2001) 3058-3065